Literature DB >> 16369712

The outcome of cervical exploration for asymptomatic and symptomatic patients with primary hyperparathyroidism.

Jaber S Abbas1, Suzan I Hashem, Walid G Faraj, Mohammad J Khalifeh, Mukbil H Horani, Ibrahim S Salti.   

Abstract

This study examined the success and safety of cervical exploration in patients with primary hyperparathyroidism (HPT). The presentation, pathologic findings, and outcome of patients with asymptomatic primary HPT were compared with those with symptomatic disease. Records of patients undergoing cervical exploration for primary HPT from January 1993 until December 31, 2003, were reviewed. Information collected consisted of preoperative symptoms, calcium and parathormone (PTH) levels, imaging studies, operative findings, pathology, and outcome of the patients. The groups with asymptomatic and symptomatic primary HPT were compared. In all, 139 patients were studied; 31 (22.3%) were asymptomatic (group I), and 108 (77.7%) had symptoms (group II). The two groups were also comparable regarding mean age, sex, and the yield of the imaging studies. The mean preoperative serum calcium level was comparable in the two groups (11.1 mg/dl versus 11.3 mg/dl). However, PTH levels were significantly lower in group I than in group II (142 pg/dl versus 283 pg/dl, P = 0.01). The weight of the adenoma was also significantly less in group I than in group II (1082 mg versus 1679 mg P = 0.079). The outcome of the surgical exploration was comparable in the two groups with an immediate success rate close to 98% and a long-term success rate of 95.4%. Cervical exploration and parathyroidectomy in patients with primary HPT is a safe procedure with a high success rate and favorable outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369712     DOI: 10.1007/s00268-005-0040-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Conservative management of primary hyperparathyroidism.

Authors:  D A Heath; E M Heath
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

Review 2.  Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology.

Authors:  H Heath
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

Review 3.  Surgical treatment of primary hyperparathyroidism.

Authors:  O H Clark
Journal:  Adv Endocrinol Metab       Date:  1995

4.  Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.

Authors:  C C Chen; L E Holder; W A Scovill; A M Tehan; D S Gann
Journal:  J Nucl Med       Date:  1997-06       Impact factor: 10.057

5.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

6.  Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels.

Authors:  R E Burney; K R Jones; B Christy; N W Thompson
Journal:  Surgery       Date:  1999-06       Impact factor: 3.982

Review 7.  Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge.

Authors:  O H Clark; W Wilkes; A E Siperstein; Q Y Duh
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

8.  Differing histologic findings after bilateral and focused parathyroidectomy.

Authors:  Hudai Genc; Eugene Morita; Nancy D Perrier; Daisha Miura; Philip Ituarte; Quan-Yang Duh; Orlo H Clark
Journal:  J Am Coll Surg       Date:  2003-04       Impact factor: 6.113

9.  The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?

Authors:  Monica S Eigelberger; W Keat Cheah; Philip H G Ituarte; Leanne Streja; Quan-Yang Duh; Orlo H Clark
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

Review 10.  Long-term health risk of primary hyperparathyroidism: the effect of surgery.

Authors:  A Sivula; R Pelkonen
Journal:  Ann Med       Date:  1996-04       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.